Polycythemia and hyperviscosity in the newborn.

Area of Science:

• Neonatal Medicine
• Pediatric Hematology
• Perinatal Research

Background:

• Polycythemia and hyperviscosity in newborns are understood to stem from intrauterine issues or birth hypoxia.
• Blood viscosity changes are primarily driven by hematocrit levels, as neonatal plasma viscosity remains normal.
• These conditions reduce blood flow to vital organs like the brain, heart, and lungs, but not the kidneys.

Purpose of the Study:

• To elucidate the etiological factors and physiological effects of neonatal polycythemia and hyperviscosity.
• To clarify the relationship between elevated hematocrit, blood viscosity, and organ-specific blood flow.
• To determine the impact of hyperviscosity and increased arterial oxygen content on cerebral and cardiac function and the efficacy of interventions.

Main Methods:

• Review of recent research (15-20 years) on neonatal polycythemia and hyperviscosity.
• Analysis of the relationship between hematocrit, plasma viscosity, and overall blood viscosity.
• Examination of the effects on blood flow to various organs, including brain, heart, lungs, and kidneys.

Main Results:

• Elevated hemoglobin and hematocrit increase arterial oxygen content, which directly reduces brain and heart blood flow and cardiac output, though brain and cardiac oxygenation remain normal.
• Decreased pulmonary blood flow is attributed to hyperviscosity, potentially causing systemic hypoxia.
• Renal plasma flow is diminished, leading to a lower glomerular filtration rate (GFR).

Conclusions:

• Partial exchange transfusion effectively lowers hematocrit and viscosity, improving pulmonary blood flow, renal function, and plasma flow.
• Neurological abnormalities in newborns with polycythemia are primarily due to initial hypoxia, not reduced cerebral blood flow.
• Therefore, partial exchange transfusion does not ameliorate short-term or long-term neurological deficits associated with these conditions.